Chiral Technologies, Inc. Advances Innovative Solutions at InformexUSA 2012

WEST CHESTER, Pa. As Chiral Technologies, Inc. (CTI) continues its advancements in enantiomeric separation science, the company remains focused on expanding the R3 Advantage family of immobilized chiral stationary phases (CSPs) by introducing a number of new immobilized phases. The R3 — Robust, Reliable, Reproducible — CSPs, offer throughput advantages for laboratories, thus minimizing expenses. These innovative CSPs can be widely used in both research and process development settings. CTI will showcase the R3 technology along with the company’s service capabilities at InformexUSA 2012, Booth 1612 (February 14-17, Ernest Morial Convention Center, New Orleans).

In line with this technology expansion of CSPs, CTI strengthens its commitment to customer support by appointing Lisa Cole Newton as National Accounts Manager, Separation Services for North America. Newton has responsibility for growing CTI’s separation services business in North America and directing company resources to more effectively meet the unique requirements of this business segment.

At InformexUSA, Joseph Barendt, Ph.D., Chief Operating Officer of Chiral Technologies, will participate in the Elsevier Tech Talks session (3:30 p.m., Thursday, February 16, Booth 950). Dr. Barendt will discuss “Steps in Commercialization of Single Enantiomer Drugs.”

About Chiral Technologies Worldwide Chiral Technologies Worldwide, the global leader in enantioselective chromatography, serves pharmaceutical and other life science industries and offers the largest portfolio of chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services. Chiral Technologies Worldwide serves the North American market through Chiral Technologies Inc. (West Chester, Pa.) and the European market through Chiral Technologies Europe SAS (Illkirch, France), wholly owned subsidiaries of Daicel Chemicals Industries Ltd. Learn more at www.chiraltech.com and www.chiral.fr.

< | >